Neurodegeneration – News and Features

Stem cell study led by the Burnham Institute researchers proves to be the first successful use of human embryonic stem cells in treating a degenerative disease.

According to Company, the center will be among the world’s first facilities to offer the processing and storing of adult stem cells for an adult’s own therapeutic use.

ACD/Labs collaborate with leading Alzheimer’s research scientist to evaluate CNS drugs, and offer a deeper understanding of the parameters that effect blood brain barrier permeability.

Senior scientist Dr Mike Gresser, with experience at Amgen and Merck will assist the drive to develop new personalised medicines.

Lorry I. Lokey, the founder of Business Wire will give $33 million to help build new laboratories for Stanford’s Institute for Stem Cell Biology and Regenerative Medicine.

The Company publishes data from its research studies identifying several candidate genetic markers, including markers in multiple genes that have never been associated with LOAD.

The 29-member Independent Citizens Oversight approves 72 grants to researchers at 20 academic and non-profit research centers throughout the state.

NGI has announced Dr. Tannin Fuja, director of research and chief scientific officer, will testify a public hearing in support of the Iowa Stem Cell Research and Cures Initiative.

CIRM's SEED grants will launch projects to explore aspects of stem cell biology in areas of medical relevance disease like Parkinson's and cancer.

Researchers aim to reveal the genetic and environmental causes behind deadly and disabling diseases.